Organotin adducts of indomethacin: synthesis, crystal structures and spectral characterization of the first organotin complexes of indomethacin

被引:27
作者
Galani, A
Kovala-Demertzi, D
Kourkoumelis, N
Koutsodimou, A
Dokorou, V
Ciunik, Z
Russo, U
Demertzis, MA [1 ]
机构
[1] Univ Ioannina, Dept Chem, GR-45110 Ioannina, Greece
[2] Univ Wroclaw, Fac Chem, PL-50383 Wroclaw, Poland
[3] Univ Padua, Dipartimento Chim Inorgan Metallorgan & Analit, I-35131 Padua, Italy
关键词
indomethacin; diorganotin; crystal structures; spectroscopic studies;
D O I
10.1016/j.poly.2004.05.004
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The complexes [Me-2(Indo)SnOSn(Indo)Me-2](2), (1) [Bu-2(Indo)SnOSn(Indo)Bu-2](2), (2), where Hindo is indomethacin, have been prepared and structurally characterized by means of Sn-119 Mossbauer, vibrational, and NMR (H-1 and C-13) spectroscopy. The crystal structures of the complexes [Me-2(Indo)SnOSn(Indo)Me-2](2) (.) 2C(4)H(8)O(2), 3 and 2 have been determined by X-ray crystallography. Each structure is centro-symmetric and features a central rhombus Sn2O2 unit with two additional tin atoms linked at the O atoms. Pairs of tin atoms are bridged by bidentate carboxylate ligands and by a monoatomic bridging oxygen. C-H --> pi, pi --> pi, stacking interactions, inter and intramolecular hydrogen bonds stabilize the structures 2 and 3. Complexes 2 and 3 are self-assembled via pi --> pi. C-H-pi and stacking interactions. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2021 / 2030
页数:10
相关论文
共 35 条
[1]   SYNTHESIS, STRUCTURE, AND SPECTROSCOPIC PROPERTIES OF COPPER(II) COMPOUNDS CONTAINING NITROGEN SULFUR DONOR LIGANDS - THE CRYSTAL AND MOLECULAR-STRUCTURE OF AQUA[1,7-BIS(N-METHYLBENZIMIDAZOL-2'-YL)-2,6-DITHIAHEPTANE]COPPER(II) PERCHLORATE [J].
ADDISON, AW ;
RAO, TN ;
REEDIJK, J ;
VANRIJN, J ;
VERSCHOOR, GC .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1984, (07) :1349-1356
[2]  
[Anonymous], 1996, HOUDINI FX
[3]  
[Anonymous], 1997, IVS ANN, P145
[4]  
BANROFT GM, 1975, INORG CHEM, V14, P2281
[5]  
BIFFIN JR, 2000, COMMUNICATION
[6]   Organotin assemblies containing Sn-O bonds [J].
Chandrasekhar, V ;
Nagendran, S ;
Baskar, V .
COORDINATION CHEMISTRY REVIEWS, 2002, 235 (1-2) :1-52
[7]  
Demertzis MA, 2000, HELV CHIM ACTA, V83, P2787, DOI 10.1002/1522-2675(20001004)83:10<2787::AID-HLCA2787>3.0.CO
[8]  
2-6
[9]   Synthesis, crystal structures and spectroscopic studies of diorganotin derivatives with mefenamic acid.: Crystal and molecular structures of 1,2:3,4-di-μ2-2-[(2,3-dimethylphenyl)amino]-benzoato-O,O-1,3-bis-2-[(-[(2,3-dimethylphenyl)amino]benzoato-O-1,2,4:2,3,4-di-μ3-oxo-tetrakis[di-methyltin(IV)] and 1,2:3,4-di-μ2-2-[(-[(-[(2,3-dimethylphenyl)amino]-benzoato-O,O-1,3-bis-2-[(-[(-[(2,3-dimethylphenyl)amino]benzoato-O-1,2,4:2,3,4-di-μ3-oxo-tetrakis[di-n-butyltin(IV)] [J].
Dokorou, V ;
Ciunik, Z ;
Russo, U ;
Kovala-Demertzi, D .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2001, 630 (02) :205-214
[10]   Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs) [J].
Duffy, CP ;
Elliott, CJ ;
O'Connor, RA ;
Heenan, MM ;
Coyle, S ;
Cleary, IM ;
Kavanagh, K ;
Verhaegen, S ;
O'Loughlin, CM ;
NicAmhlaoibh, R ;
Clynes, M .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (08) :1250-1259